Clinical trials recruiting for Lymph Node Metastases
4
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| NRT6008 Injection + Systematic chemotherapy | 1 |
Self-screener
Recruiting trials
- Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
- Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
- Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
- Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
Related conditions
Trials recruiting for Lymph Node Metastases often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Unresectable Pancreatic Cancer 7Sentinel Lymph Node 13Prostate Cancer Metastatic 27Prostate cancer 1234Pancreatic cancer 870Neoadjuvant Therapy 23Early-stage Breast Cancer 27Breast Cancer Female 61Axillary Metastases 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lymph Node Metastases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.